| Apr'19 | Apr'18 | Apr'17 | Apr'16 | Apr'15 | Apr'14 | Apr'13 | Apr'12 | Apr'11 | Apr'10 |
|---|---|---|---|---|---|---|---|---|---|
CASH FLOWS FROM OPERATING ACTIVITIES: | |||||||||
Net Loss | |||||||||
-4,215 | -21,813 | -28,159 | -55,652 | -50,358 | -35,362 | -29,780 | -42,119 | -34,151 | -14,494 |
Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||||
Depreciation and amortization | |||||||||
2,746 | 2,562 | 2,463 | 1,535 | 1,041 | 986 | 1,087 | 908 | 652 | 447 |
Stock-based compensation | |||||||||
1,595 | 1,538 | 3,363 | 4,898 | 6,702 | 6,207 | 3,435 | 2,769 | 2,837 | 1,421 |
Loss on early extinguishment of debt | |||||||||
- | - | - | - | - | - | -1,696 | 0 | 0 | - |
Amortization of discount on notes payable and debt issuance costs | |||||||||
- | - | - | - | - | - | - | 33 | 235 | 430 |
Amortization of expenses paid in shares of common stock | |||||||||
- | - | - | - | - | - | - | - | 956 | - |
Common stock issued for services | |||||||||
- | - | - | - | - | - | - | - | 40 | - |
Loss on disposal of assets | |||||||||
-127 | -1,692 | -1 | -14 | -2 | -4 | -8 | -2 | 0 | - |
Gain on sale of research and development assets | |||||||||
1,000 | 8,000 | 0 | 0 | - | - | - | - | - | - |
Amortization of expenses paid in shares of common stock | |||||||||
- | - | - | - | - | - | - | - | - | 239 |
Loss on disposal of property and equipment | |||||||||
- | - | - | - | - | - | - | - | - | 49 |
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | |||||||||
3,620 | -3,988 | 4,883 | - | - | - | - | - | - | - |
Trade and other receivables | |||||||||
- | - | - | -954 | 2,481 | -330 | -691 | 964 | 92 | 289 |
Contract assets | |||||||||
1,439 | 0 | 0 | - | - | - | - | - | - | - |
Government contract receivables | |||||||||
- | - | - | - | - | - | - | -93 | 274 | - |
Government contract receivables | |||||||||
- | - | - | - | - | - | - | - | - | 1,577 |
Inventory | |||||||||
-1,701 | -16,970 | 16,913 | 8,832 | 1,824 | 1,191 | 728 | -1,673 | -2,161 | 1,584 |
Prepaid expenses | |||||||||
- | - | - | -4 | -64 | - | - | - | - | - |
Restricted cash | |||||||||
- | - | - | 600 | 0 | 0 | - | - | - | - |
Other non-current assets | |||||||||
- | - | - | 325 | -12 | 94 | -2 | -789 | -7 | 183 |
Prepaid expenses and other assets | |||||||||
28 | -153 | -434 | - | - | 710 | -86 | -158 | 95 | -777 |
Other non-current assets | |||||||||
- | - | - | - | - | - | - | - | - | 80 |
Accounts payable | |||||||||
2,125 | -1,271 | -3,804 | -3,521 | 3,278 | -391 | -691 | -601 | 608 | -484 |
Accrued clinical trial and related fees | |||||||||
- | - | - | 3,684 | -523 | 3,503 | -1,181 | -181 | 984 | 602 |
Accrued payroll and related expenses | |||||||||
976 | -2,491 | 372 | 1,215 | 769 | 255 | 1,114 | 1,013 | -168 | 43 |
Contract liabilities | |||||||||
-5,371 | -17,582 | 11,275 | - | - | - | - | - | - | - |
Deferred revenue | |||||||||
- | - | - | 3,400 | 1,097 | 1,070 | 451 | -2,237 | 3,843 | -1,370 |
Deferred government contract revenue | |||||||||
- | - | - | - | - | - | - | - | -78 | - |
Deferred government contract revenue | |||||||||
- | - | - | - | - | - | - | - | - | -3,793 |
Customer deposits | |||||||||
- | - | - | 12,849 | 5,603 | -2,299 | 3,194 | 3,106 | -859 | 331 |
Other liabilities | |||||||||
-642 | 1,009 | -407 | 1,051 | -52 | -464 | 24 | -62 | 372 | -232 |
Assets and liabilities of discontinued operations | |||||||||
-4,550 | -2,747 | -2,911 | - | - | - | - | - | - | - |
Deferred rent, less current portion | |||||||||
- | - | - | -265 | 651 | -98 | - | - | - | - |
Deferred rent, net of current portion | |||||||||
- | - | - | - | - | - | -334 | - | - | - |
Other long-term liabilities | |||||||||
- | - | - | - | - | - | - | 258 | -26 | - |
Net cash used in operating activities | |||||||||
- | - | - | - | -36,019 | -28,254 | -20,926 | -35,878 | - | - |
Other long-term liabilities | |||||||||
- | - | - | - | - | - | - | - | - | -6 |
Net cash provided by (used in) operating activities | |||||||||
-11,595 | -25,992 | -39,169 | -39,591 | - | - | - | - | -26,462 | -13,961 |
CASH FLOWS FROM INVESTING ACTIVITIES: | |||||||||
Purchase of property and equipment | |||||||||
1,502 | 3,793 | 3,627 | 8,878 | 9,047 | 755 | 853 | 1,554 | - | - |
Property and equipment acquisitions | |||||||||
- | - | - | - | - | - | - | - | -912 | -208 |
Decrease in other assets | |||||||||
0 | 0 | -568 | -87 | -598 | 1,767 | -102 | -383 | 435 | - |
Proceeds from sale of property and equipment | |||||||||
46 | 0 | 0 | - | - | - | - | - | - | 20 |
Proceeds from sale of research and development assets | |||||||||
6,000 | 3,000 | 0 | 0 | - | - | - | - | - | - |
Net cash used in investing activities | |||||||||
- | - | - | - | -8,449 | -2,522 | -751 | -1,171 | - | - |
Net cash (used in) provided by investing activities | |||||||||
4,544 | -793 | -3,059 | -8,791 | - | - | - | - | -1,347 | -268 |
CASH FLOWS FROM FINANCING ACTIVITIES: | |||||||||
Proceeds from issuance of notes payable, net of issuance costs of $251,000 | |||||||||
- | - | - | - | - | - | 14,749 | 0 | 0 | - |
Proceeds from issuance of common stock under employee stock purchase plan | |||||||||
258 | 317 | 526 | 540 | 608 | 545 | 534 | 236 | 134 | - |
Proceeds from exercise of stock options | |||||||||
1,278 | 752 | 31 | 138 | 298 | 944 | 96 | 0 | 44 | 105 |
Proceeds from issuance of common stock, net of issuance costs | |||||||||
0 | 25,687 | 30,450 | 45,195 | 19,235 | 53,920 | - | - | - | - |
Proceeds from issuance of common stock, net of issuance costs of $513,000, $1,504,000, and $1,232,000, respectively | |||||||||
- | - | - | - | - | - | 39,522 | 33,179 | 33,087 | 25,474 |
Proceeds from issuance of preferred stock, net of issuance costs | |||||||||
0 | 0 | 1,576 | 59 | 18,203 | 17,917 | 0 | 0 | - | - |
Dividends paid on preferred stock | |||||||||
4,325 | 4,325 | 4,279 | 4,139 | 3,352 | 232 | 0 | 0 | - | - |
Principal payments on capital lease | |||||||||
- | - | - | - | - | - | - | - | 2,000 | - |
Principal payments on notes payable | |||||||||
- | - | - | - | - | - | 15,000 | 1,333 | - | 1,667 |
Payment of final fee on notes payable | |||||||||
- | - | - | - | - | - | 975 | 0 | 0 | - |
Principal payments on capital leases | |||||||||
74 | 180 | 139 | 0 | 13 | 32 | 78 | 75 | 62 | 20 |
Net cash provided by financing activities | |||||||||
- | - | - | - | 34,979 | 73,062 | 38,848 | 32,007 | - | - |
Net cash used in financing activities | |||||||||
-2,863 | 22,251 | 28,165 | 41,793 | - | - | - | - | 31,203 | 23,892 |
Change in cash, cash equivalents and restricted cash | |||||||||
-9,914 | -4,534 | -14,063 | -6,589 | -9,489 | 42,286 | 17,171 | -5,042 | 3,394 | 9,663 |
Cash paid for interest | |||||||||
- | - | - | - | 0 | 1 | 46 | 68 | 301 | 535 |
Interest paid | |||||||||
11 | 4 | 6 | 0 | - | - | - | - | - | - |
SUPPLEMENTAL DISCLOSURES OF NON-CASH ACTIVITIES: | |||||||||
Fair market value of warrants issued in connection with notes payable | |||||||||
- | - | - | - | - | - | 470 | 0 | 0 | - |
Unpaid purchases of property and equipment | |||||||||
318 | 180 | 658 | 1,565 | 4,673 | 4 | 20 | 47 | 300 | 18 |
Other receivables related to the sale of research and development assets | |||||||||
- | - | - | 0 | - | - | - | - | - | - |
Property and equipment acquired under finance lease | |||||||||
245 | 0 | 319 | 0 | 0 | - | - | - | - | 78 |
Receivable related to the sale of research and development assets | |||||||||
0 | 5,000 | 0 | - | - | - | - | - | - | - |
Lease incentives | |||||||||
- | - | - | 562 | 100 | 0 | 0 | - | - | - |
Property acquired under capital lease | |||||||||
- | - | - | - | - | - | - | - | 180 | - |
Other asset in exchange for future services | |||||||||
- | - | - | - | - | - | - | - | 233 | - |